These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 19654857)

  • 1. Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions.
    van den Berg R; van Hoogstraten I; van Agtmael M
    AIDS Rev; 2009; 11(3):157-64. PubMed ID: 19654857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
    Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
    Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients.
    Cruciani M; Mengoli C; Serpelloni G; Lanza A; Gomma M; Nardi S; Rimondo C; Bricolo F; Consolaro S; Trevisan M; Bosco O
    Vaccine; 2009 Jan; 27(1):17-22. PubMed ID: 18984022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors for predicting successful immune response to hepatitis B vaccination in HIV-1 infected patients.
    Ungulkraiwit P; Jongjirawisan Y; Atamasirikul K; Sungkanuparph S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):680-5. PubMed ID: 17883006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL; Smith V; Sands M
    Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects.
    Potsch DV; Oliveira ML; Ginuíno C; Miguel JC; Oliveira SA; Silva EF; Moreira RB; Cruz GV; Oliveira AL; Camacho LA; Barroso PF
    Vaccine; 2010 Feb; 28(6):1447-50. PubMed ID: 19995540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania.
    Pippi F; Bracciale L; Stolzuoli L; Giaccherini R; Montomoli E; Gentile C; Filetti S; De Luca A; Cellesi C
    HIV Med; 2008 Aug; 9(7):519-25. PubMed ID: 18554311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen.
    Kaech C; Pache I; Bürgisser P; Elzi L; Darling KE; Cavassini M
    J Infect; 2012 Aug; 65(2):157-64. PubMed ID: 22410383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis B vaccination effectiveness based on anti-HBs antibodies presence in children vertically infected with HIV].
    Ołdakowska A; Marczyńska M
    Przegl Epidemiol; 2010; 64(2):323-8. PubMed ID: 20731246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.
    Lopes VB; Hassing RJ; de Vries-Sluijs TE; El Barzouhi A; Hansen BE; Schutten M; de Man RA; van der Ende ME
    Vaccine; 2013 Feb; 31(7):1040-4. PubMed ID: 23273969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice.
    Mena G; Llupià A; García-Basteiro AL; Díez C; León A; García F; Bayas JM
    Vaccine; 2012 May; 30(24):3703-9. PubMed ID: 22446635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients.
    de Vries-Sluijs TE; Hansen BE; van Doornum GJ; Springeling T; Evertsz NM; de Man RA; van der Ende ME
    J Infect Dis; 2008 Jan; 197(2):292-4. PubMed ID: 18177248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus.
    Laurence JC
    Am J Med; 2005 Oct; 118 Suppl 10A():75S-83S. PubMed ID: 16271546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor responses to recombinant HBV vaccination in patients with HIV infection.
    Pasricha N; Datta U; Chawla Y; Singh S; Arora SK; Sud A; Minz RW; Saikia B; Singh H; James I; Sehgal S
    Trop Gastroenterol; 2005; 26(4):178-82. PubMed ID: 16737046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy.
    Paitoonpong L; Suankratay C
    Scand J Infect Dis; 2008; 40(1):54-8. PubMed ID: 17852939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose.
    Fonseca MO; Pang LW; de Paula Cavalheiro N; Barone AA; Heloisa Lopes M
    Vaccine; 2005 Apr; 23(22):2902-8. PubMed ID: 15780739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
    O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
    HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.